Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants.
about
Probiotic Supplementation in Preterm Infants Does Not Affect the Risk of Bronchopulmonary Dysplasia: A Meta-Analysis of Randomized Controlled Trials.Recent Advances in Bronchopulmonary Dysplasia: Pathophysiology, Prevention, and Treatment.Advantages of Graphene Biosensors for Human Stem Cell Therapy Potency Assays.Treatment of Hyperoxia-Induced Lung Injury with Lung Mesenchymal Stem Cells in Mice
P2860
Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Mesenchymal stem cells for the ...... dysplasia in preterm infants.
@en
Mesenchymal stem cells for the ...... dysplasia in preterm infants.
@nl
type
label
Mesenchymal stem cells for the ...... dysplasia in preterm infants.
@en
Mesenchymal stem cells for the ...... dysplasia in preterm infants.
@nl
prefLabel
Mesenchymal stem cells for the ...... dysplasia in preterm infants.
@en
Mesenchymal stem cells for the ...... dysplasia in preterm infants.
@nl
P2860
P1476
Mesenchymal stem cells for the ...... dysplasia in preterm infants.
@en
P2093
Bernard Thébaud
Maria Pierro
P2860
P304
P356
10.1002/14651858.CD011932.PUB2
P50
P577
2017-11-10T00:00:00Z